This has been shown in pancreatic adenocarcinoma where the promoter of BNIP3 turned out to be methylated in all BNIP3-negative pancreatic cancer cell lines and in eight out of 10 pancreatic adenocarcinoma samples [12]. This evidence concerns the gene BNIP3 and pancreatic adenocarcinoma.